The Mississippi Society of Oncology was formed in 1991 for the purpose ofpromoting the highest professional standards of oncology in Mississippi, to study, research and exchange information, experiences and ideas leading to improvement in oncology and promote educational opportunities.
In addition, the MOS is committed to support the search for more effective treatments of malignant diseases, work with other organizations and societies that have concerns with cancer care, and disseminate information regarding regulatory developments affecting members.
And finally the MOS acts as a resource for insurers regarding the standard of care in oncology and represents the practice of oncology and hematology in the State of Mississippi.
No one should have to fight Cancer alone. Join Amgen and six independent non-profit organizations that span the continuum of cancer care. The information and resources within these pages has been provided by the Breakaway from Cancer partners. Amgen has no control over these programs and provides information as a courtesy only.
Jan. 27, 2020 - CMS: Medicare Will Cover Genetic Diagnostics for Certain Cancers, Find out more
Jan. 23, 2020 - Blue Cross Insurers to Create Their Own Drug Company Amid Price Fight,
Find out more
Jan. 15, 2020 - American Cancer Survivors Face Substantial Financial Hardship and Sacrifices,
Find out more
Jan. 8, 2020 - US Cancer Death Rate Drops by Most on Record, Find out more
IMPORTANT INFORMATION FOR ALL PROVIDERS
FROM THE AMERICAN MEDICAL ASSOCIATION
As of January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients. Find out more
No upcoming events
Improving Seniors’ Timely Access to Care Act of 2019
The Mississippi Society of Oncology is proud to have joined with hundreds of other health organizations to support the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107) recently introduced by Reps. Suzan DelBene (D-WA), Mike Kelly (R-PA), Roger Marshall, MD (R-KS), and Ami Bera, MD (D-CA).
Patient-Centered Oncology Payment Model Submitted to HHS Alternative Payment Model Advisory Group Find out more
Congress Raises Tobacco Purchasing Age, Increases Federal Investment in Cancer ResearchFind out more
Medical Oncology: Learning & Assessment Now Open for RegistrationFind out more
Patient-Centered Standards for Medically Integrated Dispensing
ASCO has partnered with the National Community Oncology Dispensing Association (NCODA)to create joint evidence-based standards for medically integrated in-office dispensing of oral anti-cancer drugs and supportive care medications.Find out More